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Requirements for clinical PET: 
the situation in Switzerland
Dear Sir,
I would like to comment on the article by Bedford and
Maisey referring to the availability and requirements for
clinical PET in Europe [1]. While this may be a minor
point, Tables 3 and 5 both state that there are no PET
scanners in Switzerland, although Prof. Maisey is well
aware of our work. This is somewhat surprising. To 
clarify matters:
1. There are currently two PET-CT and seven PET scan-
ners in Switzerland, a somewhat indeterminate fraction
of which are used for research purposes (around two).
2. The number of scans done for NSCLC in Switzerland
in 2003 was 1,582; thus underuse of PET in NSCLC
in Switzerland is slightly more than 1,000, according
to Table 3.
3. The suggestion that 2,500–2,600 patients can be
scanned on a single PET scanner (Table 3, second
column, row Switzerland) may be correct in principle,
but in practice I would be interested to know who in
Europe is able to examine this many patients on a 
single scanner. Note that we did 2,100 PET-CT scans
on a single PET-CT scanner in 2003, which is al-
ready a substantial load. It should not be forgotten
that the number of scans done on a PET scanner is
very much dependent on the type of scanner, the scan-
ning protocol and, probably above all, the availability
of FDG.
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Requirements for clinical PET: 
clarification of the situation in Sweden
Dear Sir,
We read with great interest the paper by Bedford and
Maisey in which a method for assessing the requirements
for introduction of positron emission tomography (PET)
as a cancer imaging service was presented [1]. Studies
like these, which attempt to objectify the actual need for
a medical service, are important. We understand that
simplifications had to be made in the study, and that the
authors had to rely on the information most readily ob-
tainable from different national sources.
Nevertheless, basic facts need to be as correct as pos-
sible, and we observe that neither the cited number of
dedicated PET cameras nor information on their use for
clinical examinations in Sweden is correct. The number
of dedicated (human) PET scanners is stated to be seven,
while there have never been more than a maximum of
five in our country. One of them is an old and inefficient
camera with limited usefulness, and this can hardly be
included in the current survey. Consequently, there are 
in reality only four dedicated PET cameras in use in
Sweden.
Furthermore, while Sweden has had a very active and
long-standing tradition in PET (in Uppsala and Stock-
holm), this tradition has to a very large degree been 
directed towards basic research and methodological de-
velopments. It is only during the past few years that clin-
ical PET in Sweden has achieved a “breakthrough” com-
parable to that happening internationally. Consequently,
a correction regarding the number of cameras, similar to
that made for the UK (Table 4 in the paper), is also nec-
essary for Sweden. It is stated that in the UK there are 13
dedicated scanners, of which seven are in clinical use
and six are research instruments. In Sweden, two dedi-
cated PET cameras are effectively used for clinical pur-
poses. This moves us from the authors’ calculated posi-
tion of number 2 in Europe (with 196.07% of the number
of scanners required), to sixth position, with only
56.02% available. After this adjustment, we lack two
scanners instead of having an excess of three, according
to the authors’ model of estimated needs!
We would like to emphasise that we do not intend to
criticise the authors’ work or the method they present.
We acknowledge that it is very difficult to analyse the
imaging situation in accurate detail in all 36 different
countries included. However, we do need to correct 
the unfortunately misleading information regarding the
number of dedicated PET cameras currently available
